Richard B. Bartram

2021

In 2021, Richard B. Bartram earned a total compensation of $3.3M as Former Chief Financial Officer at Esperion Therapeutics, a 35% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$84,000
Option Awards$1,895,559
Salary$411,667
Stock Awards$922,306
Other$9,750
Total$3,323,282

Bartram received $1.9M in option awards, accounting for 57% of the total pay in 2021.

Bartram also received $84K in non-equity incentive plan, $411.7K in salary, $922.3K in stock awards and $9.8K in other compensation.

Rankings

In 2021, Richard B. Bartram's compensation ranked 4,024th out of 12,415 executives tracked by ExecPay. In other words, Bartram earned more than 67.6% of executives.

ClassificationRankingPercentile
All
4,024
out of 12,415
68th
Division
Manufacturing
1,650
out of 5,505
70th
Major group
Chemicals And Allied Products
683
out of 2,375
71st
Industry group
Drugs
606
out of 2,096
71st
Industry
Pharmaceutical Preparations
425
out of 1,546
73rd

Pay ratio

Richard B. Bartram's Pay$3,323,282
Median Employee's Pay$217,116
Pay Ratio

15

to 1

In 2021, the annual total compensation of Richard B. Bartram was $3,323,282.

The annual total compensation of the median employee at Esperion Therapeutics was $217,116.

The ratio of Richard B. Bartram's pay to the pay of median employee was therefore 15 to one.

Source: SEC filing on April 14, 2022.

Bartram's colleagues

We found four more compensation records of executives who worked with Richard B. Bartram at Esperion Therapeutics in 2021.

2021

Tim Mayleben

Esperion Therapeutics

Chief Executive Officer

2021

Sheldon Koenig

Esperion Therapeutics

Chief Executive Officer

2021

JoAnne Foody

Esperion Therapeutics

Chief Medical Officer

2021

Ashley Hall

Esperion Therapeutics

Former Chief Development Officer

News

In-depth

You may also like